CBPD-409   Click here for help

GtoPdb Ligand ID: 13301

Synonyms: CBPD409 | compound 25 [PMID: 38530938]
Compound class: Synthetic organic
Comment: CBPD-409 is an orally bioactive PROTAC degrader that targets the CBP (CREB binding protein) and p300 (E1A binding protein p300) proteins [1]. It binds to the target proteins using a GNE-049-derived moiety, and a thalidomide ligand is used to interact with the cereblon E3 ubiquitin ligase.
CBP and p300 are bromodomain and histone acetyltransferase (HAT) domain-containing proteins that act as androgen receptor transcriptional coactivators. CBPD-409 was designed to disrupt CBP/p300-induced androgen receptor expression in prostate cancers.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 15
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 144.78
Molecular weight 862.97
XLogP 2.82
No. Lipinski's rules broken 2

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=O)N1CCC2=C(C1)C(=NN2[C@H]3CC[C@@H](CC3)CN4CCN(CC4)C5=CC=C6C(=C5)C(=O)N(C7CCC(=O)NC7=O)C6=O)N8CCCC9=CC(=C(C=C98)C(F)F)C%10=CN(C)N=C%10
Isomeric SMILES O=C1CCC(N2C(=O)C3=CC=C(C=C3C2=O)N4CCN(C[C@@H]5CC[C@H](CC5)N6N=C(N7CCCC8=C7C=C(C(C=9C=NN(C9)C)=C8)C(F)F)C%10=C6CCN(C%10)C(C)=O)CC4)C(N1)=O
InChI InChI=1S/C46H52F2N10O5/c1-27(59)55-15-13-38-37(26-55)43(56-14-3-4-29-20-34(30-23-49-52(2)25-30)35(42(47)48)22-40(29)56)51-58(38)31-7-5-28(6-8-31)24-53-16-18-54(19-17-53)32-9-10-33-36(21-32)46(63)57(45(33)62)39-11-12-41(60)50-44(39)61/h9-10,20-23,25,28,31,39,42H,3-8,11-19,24,26H2,1-2H3,(H,50,60,61)/t28-,31-,39?
InChI Key CXJGNQXWKVPWMM-KEQSSBIPSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
CBP/p300 degradation with DC50 0.2-0.4 nM in prostate cancer cell lines; nanomolar antiproliferative potency in AR+ve prostate cancer cell lines, with anti-tumour efficacy in the mouse VCaP xenograft model following oral administration [1].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CREB binding protein Hs None Binding - - - 1
PROTAC [1]
E1A binding protein p300 Hs None Binding - - - 1
PROTAC [1]